{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for glutathione root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
NCT03631706: Phase 3 Interventional Completed Non-small Cell Lung Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02544438: Phase 1/Phase 2 Interventional Completed Acute Myeloid Leukemia
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04386616: Phase 2 Interventional Completed COVID-19 Pneumonia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:gruticibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00215644: Phase 2 Interventional Completed Esophageal Cancer
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03964233: Phase 1 Interventional Active, not recruiting Neoplasms
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ladiratuzumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:cofetuzumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03516981: Phase 2 Interventional Active, not recruiting Advanced Non-Small Cell Lung Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:mupadolimab [INN]
Source URL:
Class:
PROTEIN